Cannabix Technol Stock Price, News & Analysis

Cannabix Technologies Inc. has partnered with the North Louisiana Criminalistics Laboratory (NLCL) to advance marijuana breathalyzer technology. This collaboration aims to enhance public safety by utilizing Cannabix's MS Breath Sampler for testing THC in breath samples. The NLCL will host this technology, enabling more efficient analysis of THC concentrations. Cannabix's approach simplifies the testing process, reducing time and costs significantly compared to traditional methods. CEO Rav Mlait expressed enthusiasm over this installation, marking a significant step in developing practical drug-screening devices for law enforcement and workplaces.

Cannabix Technologies is pioneering marijuana breathalyzer devices aimed at enhancing public safety. The company has partnered with the Warren County District Attorney’s office in Pennsylvania to pilot its breath collection units (BCU) for detecting THC in breath samples. The pilot program will see the deployment of two BCUs for potential usage over three months, targeting impaired driving detection. Cannabix's technology could revolutionize law enforcement protocols regarding cannabis consumption, aligning more closely with impairment timing and improving road safety.

Cannabix Technologies Inc. (CSE: BLO, OTC PINK: BLOZF) is advancing marijuana breathalyzer technology to enhance public safety. They are participating in a multi-analysis study in mid-October to test a new version of their FAIMS technology for detecting THC in breath. This follows prior testing events in June and July. The proprietary breath capture system minimizes sample preparation and significantly reduces analysis time, offering a promising alternative to traditional drug screening methods. Results indicate a consistent correlation between breath and blood THC levels, positioning Cannabix as a pioneer in cannabis impairment detection.

Cannabix Technologies continues to advance its marijuana breathalyzer technology, reporting progress in a comprehensive study conducted in the southern United States. The company’s FAIMS technology aims to detect THC in breath, correlating well with blood test results. Recent tests have demonstrated effective breath sample collection and analysis, eliminating traditional preparation steps and reducing costs. Cannabix seeks collaboration with law enforcement and other agencies to further develop these groundbreaking methods, while CEO Rav Mlait emphasizes their commitment to improving public safety.

Cannabix Technologies is advancing its marijuana breathalyzer technology aimed at enhancing public safety through detection of THC impairment. Participating in a multi-analysis study with law enforcement in the southern US, the company is using its proprietary Breath Collection Unit and MS Breath Sampler to analyze breath samples alongside traditional drug screening methods. The results of the study are anticipated to provide valuable data for regulators and law enforcement, supporting practical impairment identification.

Cannabix Technologies Inc. is advancing the development of marijuana breathalyzer devices aimed at enhancing public safety for law enforcement and employers. The company will present its research on the correlation of breath and blood cannabis levels at the Breath Summit 2022 in June. Their innovative technologies, including the THC Breath Analyzer, demonstrate promising results in detecting THC levels through breath samples, with rapid results and no sample preparation needed. Discussions with law enforcement are ongoing to test this hardware for practical applications.

Cannabix Technologies Inc. has successfully tested its marijuana breathalyzer technology, designed for law enforcement and workplace use, showing a strong correlation between THC levels in breath and blood plasma. This independent study, led by Dr. Phillip Olla, demonstrated that breath samples can be analyzed with Cannabix's handheld Breath Collection Unit and Mass Spectrometer within seconds, significantly reducing laboratory analysis times. The device, which requires no sample preparation, is in advanced prototype testing, aiming to enhance public safety by identifying recent marijuana use.

Cannabix Technologies has developed a Contactless Alcohol Breathalyzer (CAB) for vehicle cabins, responding to an inquiry from a major auto parts manufacturer. This prototype allows drivers to provide breath samples without a mouthpiece. The CAB technology could potentially be integrated into new safety standards mandated by the U.S. Infrastructure Investment and Jobs Act for impaired driving detection. While a provisional patent has been filed, the technology is still in preapproval stages, and no commercial sales are currently planned.